Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2018-02-02 Issue:4 Volume:78 Page:453-462
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Awad Kamal^ORCID, ,Mikhailidis Dimitri P.,Katsiki Niki,Muntner Paul,Banach Maciej

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-018-0870-1/fulltext.html

Reference66 articles.

1. Berg K. A new serum type system in man—the Lp system. Acta Pathol Microbiol Scand. 1963;59:369–82.

2. Hoover-Plow J, Huang M. Lipoprotein(a) metabolism: potential sites for therapeutic targets. Metabolism. 2013;62:479–91.

3. Banach M. Lipoprotein(a)—we know so much yet still have much to learn …. J. Am. Heart Assoc. 2016;5:e003597.

4. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H. Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci. 1996;33:495–543.

5. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132–7.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

2. Lipoprotein(a) - gaining clinical importance as a cardiovascular risk factor. Current state of medical knowledge.;Prospects in Pharmaceutical Sciences;2024-08-14

3. Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review;International Journal of Molecular Sciences;2024-08-13

4. Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition – a case based review;Expert Review of Cardiovascular Therapy;2024-08-02

5. The prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the Polish population. The first results from the PMMHRI-Lp(a) Registry;Progress in Cardiovascular Diseases;2024-08